America's Top Tradeshow Directory | Events In America
Facebook Linked In Twitter Videos

Event Contacts

Andrew Juurinen
Xtalks Webinars
1235 Bay Street, Suite 802
Toronto, ON M6G 1X5
(416) 977-6555

Event Description

Pharmacovigilance (PV) is a challenging field and identifying and minimising risks is a complex process never more so than in early phase clinical trials. New adverse events (AEs) continue to be added to the list of expected events for a product years after it has been licensed and treated millions of people. So how can a Sponsor hope to characterise the safety of an Investigational Medicinal Product (IMP) during their early phase ‘safety’ studies, with such limited data and patient numbers? Why is it so important to get it right at this stage and what are the knock-on effects if it is done badly?

This webinar looks to highlight some of the major challenges of PV in early phase clinical trials and what can be done to overcome them. There will be a particular focus on oncology, where patients can be expected to have multiple complex and confounding comorbidities and treatments.

This session is designed for those starting out in their drug safety career in clinical trials, or those with post-marketing experience looking for a change in focus.

Not sure if you want to exhibit at or attend the The Challenges of Pharmacovigilance in Early Phase Clinical Trials? See the panels below to get the information you need to make an informed decision.

All information in Events In America is deemed to be accurate at the time we add it, and we take steps to verify all details and update our records when new information is provided, but as people, events and circumstances change, we caution users to independently confirm all information. and Events In America LLC make no guarantee of accuracy and assume no liability for inaccurate information.

Event Details

Conference/Event Dates: 04/27/2016 - 04/27/2016
Classification: B2B
Primary Industry: Clinical Pharmacology
Other Industries: Clinical Pharmacology, Professional Healthcare
Audience: Intermediate professionals who currently work in clinical trials, working in post marketing with an interest in PV.

Influencers or decisions makers in clinical trials who are interested in outsourcing PV.

Clinicians who may not be aware of the benefits of a targeted PV approach further down the developmental path of an IMP.

Booth Details

Booth Size Booth Cost   Available Amenities
No exhibiting.   Electricity: n/a
  Water: n/a
  Generator: n/a
  Marketing Vehicles Allowed: n/a
Other Booth Sizes Available: n/a

Advance Networking

How do I show up here?
Mark Travers

Personal Notes

Add a note here, it is only visible by you.

New Search Contact This Event
The Challenges of Pharmacovigilance in Early Phase Clinical Trials

exhibitor lists